BIOMAT Database Logo BIOMAT Database Logo

Interaction of the phosphotyrosine interaction/phosphotyrosine binding-related domains of Fe65 with wild-type and mutant Alzheimer's beta-amyloid precursor proteins. 1997

N Zambrano, and J D Buxbaum, and G Minopoli, and F Fiore, and P De Candia, and S De Renzis, and R Faraonio, and S Sabo, and J Cheetham, and M Sudol, and T Russo
Dipartimento di Biochimica e Biotecnologie Mediche, Università degli Studi di Napoli Federico II, CEINGE Biotecnologie Avanzate s.c. r.l., via S. Pansini 5, 80131 Naples, Italy.

The two tandem phosphotyrosine interaction/phosphotyrosine binding (PID/PTB) domains of the Fe65 protein interact with the intracellular region of the Alzheimer's beta-amyloid precursor protein (APP). This interaction, previously demonstrated in vitro and in the yeast two hybrid system, also takes place in vivo in mammalian cells, as demonstrated here by anti-Fe65 co-immunoprecipitation experiments. This interaction differs from that occurring between other PID/PTB domain-containing proteins, such as Shc and insulin receptor substrate 1, and activated growth factor receptors as follows: (i) the Fe65-APP interaction is phosphorylation-independent; (ii) the region of the APP intracellular domain involved in the binding is larger than that of the growth factor receptor necessary for the formation of the complex with Shc; and (iii) despite a significant similarity the carboxyl-terminal regions of PID/PTB of Fe65 and of Shc are not functionally interchangeable in terms of binding cognate ligands. A role for Fe65 in the pathogenesis of familial Alzheimer's disease is suggested by the finding that mutant APP, responsible for some cases of familial Alzheimer's disease, shows an altered in vivo interaction with Fe65.

UI MeSH Term Description Entries
D008969 Molecular Sequence Data Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories. Sequence Data, Molecular,Molecular Sequencing Data,Data, Molecular Sequence,Data, Molecular Sequencing,Sequencing Data, Molecular
D009419 Nerve Tissue Proteins Proteins, Nerve Tissue,Tissue Proteins, Nerve
D009687 Nuclear Proteins Proteins found in the nucleus of a cell. Do not confuse with NUCLEOPROTEINS which are proteins conjugated with nucleic acids, that are not necessarily present in the nucleus. Nucleolar Protein,Nucleolar Proteins,Nuclear Protein,Protein, Nuclear,Protein, Nucleolar,Proteins, Nuclear,Proteins, Nucleolar
D010766 Phosphorylation The introduction of a phosphoryl group into a compound through the formation of an ester bond between the compound and a phosphorus moiety. Phosphorylations
D011233 Precipitin Tests Serologic tests in which a positive reaction manifested by visible CHEMICAL PRECIPITATION occurs when a soluble ANTIGEN reacts with its precipitins, i.e., ANTIBODIES that can form a precipitate. Precipitin Test,Test, Precipitin,Tests, Precipitin
D011485 Protein Binding The process in which substances, either endogenous or exogenous, bind to proteins, peptides, enzymes, protein precursors, or allied compounds. Specific protein-binding measures are often used as assays in diagnostic assessments. Plasma Protein Binding Capacity,Binding, Protein
D011506 Proteins Linear POLYPEPTIDES that are synthesized on RIBOSOMES and may be further modified, crosslinked, cleaved, or assembled into complex proteins with several subunits. The specific sequence of AMINO ACIDS determines the shape the polypeptide will take, during PROTEIN FOLDING, and the function of the protein. Gene Products, Protein,Gene Proteins,Protein,Protein Gene Products,Proteins, Gene
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000544 Alzheimer Disease A degenerative disease of the BRAIN characterized by the insidious onset of DEMENTIA. Impairment of MEMORY, judgment, attention span, and problem solving skills are followed by severe APRAXIAS and a global loss of cognitive abilities. The condition primarily occurs after age 60, and is marked pathologically by severe cortical atrophy and the triad of SENILE PLAQUES; NEUROFIBRILLARY TANGLES; and NEUROPIL THREADS. (From Adams et al., Principles of Neurology, 6th ed, pp1049-57) Acute Confusional Senile Dementia,Alzheimer's Diseases,Dementia, Alzheimer Type,Dementia, Senile,Presenile Alzheimer Dementia,Senile Dementia, Alzheimer Type,Alzheimer Dementia,Alzheimer Disease, Early Onset,Alzheimer Disease, Late Onset,Alzheimer Sclerosis,Alzheimer Syndrome,Alzheimer Type Senile Dementia,Alzheimer's Disease,Alzheimer's Disease, Focal Onset,Alzheimer-Type Dementia (ATD),Dementia, Presenile,Dementia, Primary Senile Degenerative,Early Onset Alzheimer Disease,Familial Alzheimer Disease (FAD),Focal Onset Alzheimer's Disease,Late Onset Alzheimer Disease,Primary Senile Degenerative Dementia,Senile Dementia, Acute Confusional,Alzheimer Dementias,Alzheimer Disease, Familial (FAD),Alzheimer Diseases,Alzheimer Type Dementia,Alzheimer Type Dementia (ATD),Alzheimers Diseases,Dementia, Alzheimer,Dementia, Alzheimer-Type (ATD),Familial Alzheimer Diseases (FAD),Presenile Dementia,Sclerosis, Alzheimer,Senile Dementia
D000595 Amino Acid Sequence The order of amino acids as they occur in a polypeptide chain. This is referred to as the primary structure of proteins. It is of fundamental importance in determining PROTEIN CONFORMATION. Protein Structure, Primary,Amino Acid Sequences,Sequence, Amino Acid,Sequences, Amino Acid,Primary Protein Structure,Primary Protein Structures,Protein Structures, Primary,Structure, Primary Protein,Structures, Primary Protein

Related Publications

N Zambrano, and J D Buxbaum, and G Minopoli, and F Fiore, and P De Candia, and S De Renzis, and R Faraonio, and S Sabo, and J Cheetham, and M Sudol, and T Russo
The regions of the Fe65 protein homologous to the phosphotyrosine interaction/phosphotyrosine binding domain of Shc bind the intracellular domain of the Alzheimer's amyloid precursor protein.
December 1995, The Journal of biological chemistry,
N Zambrano, and J D Buxbaum, and G Minopoli, and F Fiore, and P De Candia, and S De Renzis, and R Faraonio, and S Sabo, and J Cheetham, and M Sudol, and T Russo
The phosphotyrosine interaction domains of X11 and FE65 bind to distinct sites on the YENPTY motif of amyloid precursor protein.
November 1996, Molecular and cellular biology,
N Zambrano, and J D Buxbaum, and G Minopoli, and F Fiore, and P De Candia, and S De Renzis, and R Faraonio, and S Sabo, and J Cheetham, and M Sudol, and T Russo
The Fe65 and X11 families of proteins: proteins that interact with the Alzheimer's disease amyloid precursor protein.
August 1998, Biochemical Society transactions,
N Zambrano, and J D Buxbaum, and G Minopoli, and F Fiore, and P De Candia, and S De Renzis, and R Faraonio, and S Sabo, and J Cheetham, and M Sudol, and T Russo
Regulation of beta-amyloid secretion by FE65, an amyloid protein precursor-binding protein.
March 1999, The Journal of biological chemistry,
N Zambrano, and J D Buxbaum, and G Minopoli, and F Fiore, and P De Candia, and S De Renzis, and R Faraonio, and S Sabo, and J Cheetham, and M Sudol, and T Russo
Characterization of an amyloid precursor protein-binding protein Fe65L2 and its novel isoforms lacking phosphotyrosine-interaction domains.
November 2002, The Biochemical journal,
N Zambrano, and J D Buxbaum, and G Minopoli, and F Fiore, and P De Candia, and S De Renzis, and R Faraonio, and S Sabo, and J Cheetham, and M Sudol, and T Russo
Phosphorylation-dependent regulation of the interaction of amyloid precursor protein with Fe65 affects the production of beta-amyloid.
October 2001, The Journal of biological chemistry,
N Zambrano, and J D Buxbaum, and G Minopoli, and F Fiore, and P De Candia, and S De Renzis, and R Faraonio, and S Sabo, and J Cheetham, and M Sudol, and T Russo
Interaction of Alzheimer's beta -amyloid precursor family proteins with scaffold proteins of the JNK signaling cascade.
May 2002, The Journal of biological chemistry,
N Zambrano, and J D Buxbaum, and G Minopoli, and F Fiore, and P De Candia, and S De Renzis, and R Faraonio, and S Sabo, and J Cheetham, and M Sudol, and T Russo
Mapping of the human and murine X11-like genes (APBA2 and apba2), the murine Fe65 gene (Apbb1), and the human Fe65-like gene (APBB2): genes encoding phosphotyrosine-binding domain proteins that interact with the Alzheimer's disease amyloid precursor protein.
June 1998, Mammalian genome : official journal of the International Mammalian Genome Society,
N Zambrano, and J D Buxbaum, and G Minopoli, and F Fiore, and P De Candia, and S De Renzis, and R Faraonio, and S Sabo, and J Cheetham, and M Sudol, and T Russo
cDNA cloning and chromosome mapping of the human Fe65 gene: interaction of the conserved cytoplasmic domains of the human beta-amyloid precursor protein and its homologues with the mouse Fe65 protein.
October 1996, Human molecular genetics,
N Zambrano, and J D Buxbaum, and G Minopoli, and F Fiore, and P De Candia, and S De Renzis, and R Faraonio, and S Sabo, and J Cheetham, and M Sudol, and T Russo
Wild type and mutant amyloid precursor proteins influence downstream effects of proteasome and autophagy inhibition.
February 2014, Biochimica et biophysica acta,
Copied contents to your clipboard!